Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Eflornithine × Clear all

NCT06059118 2026-01-14

Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

Phase 2 Recruiting

Prostatic Neoplasms

NCT00006101 2018-05-14

Eflornithine in Treating Patients At High Risk of Developing Prostate Cancer

Phase 2 Completed

76 enrolled 7 charts

Prostatic Neoplasms